Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Interest & Investment Income: 2012-2024

Historic Interest & Investment Income for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to $20.3 million.

  • Ocular Therapeutix's Interest & Investment Income fell 34.04% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year decrease of 8.14%. This contributed to the annual value of $20.3 million for FY2024, which is 409.21% up from last year.
  • Latest data reveals that Ocular Therapeutix reported Interest & Investment Income of $20.3 million as of FY2024, which was up 409.21% from $4.0 million recorded in FY2023.
  • Ocular Therapeutix's 5-year Interest & Investment Income high stood at $20.3 million for FY2024, and its period low was $33,000 during FY2021.
  • For the 3-year period, Ocular Therapeutix's Interest & Investment Income averaged around $8.4 million, with its median value being $4.0 million (2023).
  • As far as peak fluctuations go, Ocular Therapeutix's Interest & Investment Income slumped by 86.33% in 2020, and later soared by 2,318.18% in 2022.
  • Over the past 5 years, Ocular Therapeutix's Interest & Investment Income (Yearly) stood at $168,000 in 2020, then crashed by 80.36% to $33,000 in 2021, then spiked by 2,318.18% to $798,000 in 2022, then skyrocketed by 399.12% to $4.0 million in 2023, then spiked by 409.21% to $20.3 million in 2024.